Recombinant Escherichia coli Lipoprotein-releasing system ATP-binding protein LolD (lolD)

What is the role of LolD in the bacterial lipoprotein transport pathway?

LolD functions as the ATP-binding protein component of the LolCDE complex, which initiates the localization of lipoproteins (Lol) export pathway in gram-negative bacteria. This ABC transporter complex selectively extracts and transports lipoproteins from the inner membrane for trafficking to the outer membrane. While lipoprotein entry into the LolCDE complex is ATP-independent, the transport of lipoproteins to LolA requires ATP hydrolysis mediated by LolD . This protein is critical for bacterial envelope biogenesis and plays an essential role in sorting lipoproteins that perform diverse functions including microbe-host interactions.

How does LolD interact with other components of the LolCDE complex?

LolD forms the nucleotide-binding domain of the LolCDE ABC transporter, working in conjunction with LolC and LolE, which form the transmembrane domains. Cryo-EM structural analysis at 3.5 to 4.2 Å resolution has revealed that LolD undergoes conformational changes upon binding of ATP or its non-hydrolyzable analog AMPPNP . These structural changes are transmitted to LolC and LolE, altering the V-shaped cavity that accommodates lipoprotein substrates. Structure-based disulfide cross-linking and photo-crosslinking experiments have confirmed these interactions and their functional significance in the transport cycle .

What are the distinctive characteristics of the ATP-binding domain in LolD?

The ATP-binding domain of LolD contains the characteristic Walker A and Walker B motifs found in ABC transporters. The catalytic glutamate residue at position 171 (E171) is particularly important, as mutation to glutamine (E171Q) results in a catalytically inactive protein that can still bind ATP but cannot hydrolyze it . This mutation has been instrumental in studying the role of ATP hydrolysis in lipoprotein transport. The ATP-binding domain undergoes significant conformational changes during the transport cycle, transitioning from an open state in the apo form to a closed state when bound to ATP.

Which E. coli strains are most suitable for recombinant expression of LolD?

For successful expression of recombinant LolD, E. coli strains with the DE3 genotype are particularly suitable as they contain the T7 promoter system that drives high expression levels of the target protein. Strains deficient in proteases such as Lon and OmpT (like BL21(DE3)) can reduce proteolysis of the expressed LolD protein . For expression of the complete LolCDE complex, consider using strains with enhanced capacity to correctly fold proteins with multiple disulfide bonds, such as those with gor or trxB mutations . If co-expression with lipoproteins is desired, strains containing the pRARE plasmid may enhance expression by providing tRNAs for rare codons not normally used in E. coli translation .

What expression systems and vectors are optimal for producing functional LolD protein?

For functional expression of LolD, vectors with inducible promoter systems are recommended, particularly those using IPTG-inducible T7 promoters. This allows cells to be grown to appropriate density before initiating expression of potentially toxic recombinant proteins . For the complete LolCDE complex, consider vectors with the lacIq mutation to ensure tight regulation and prevent leaky expression . When studying ATP hydrolysis activity, it's beneficial to use expression systems that allow for site-directed mutagenesis, such as introducing the E171Q mutation for comparative analysis of ATP binding versus hydrolysis .

How can researchers effectively reconstitute LolD/LolCDE in nanodiscs for functional studies?

To reconstitute LolCDE in nanodiscs for functional studies:

• Express and purify LolCDE complex with appropriate detergents

• Mix purified LolCDE with membrane scaffold proteins and phospholipids

• Remove detergent using Bio-Beads or dialysis

• Purify the nanodisc-embedded LolCDE complex using size exclusion chromatography

For functional validation, reconstituted LolCDE can be tested with lipoprotein substrates such as RcsF. The functionality of nanodisc-embedded LolCDE can be assessed through photo-crosslinking experiments with RcsF and ATP dependency tests. According to experimental findings, nanodisc-embedded wild-type LolCDE can transfer RcsF to LolA in the presence of ATP and Mg2+, while the catalytically inactive LolD(E171Q) mutant cannot facilitate this transfer despite allowing lipoprotein entry .

What is the mechanism of ATP hydrolysis by LolD and how does it drive lipoprotein transport?

The ATP hydrolysis mechanism of LolD involves several distinct steps in the lipoprotein transport cycle:

• Lipoprotein entry into the V-shaped cavity of LolCDE is ATP-independent

• ATP binding to LolD induces conformational changes in the LolCDE complex

• ATP hydrolysis is required specifically for the transfer of lipoproteins from LolCDE to LolA

In vitro lipoprotein transfer assays have demonstrated that conditions that interfere with ATP hydrolysis (addition of EDTA, VO4-, or non-hydrolyzable AMPPNP) prevent the transfer of lipoproteins to LolA . Similarly, the catalytically inactive LolD(E171Q) mutant allows lipoprotein entry but fails to facilitate transfer to LolA, confirming that ATP hydrolysis is essential for this step of the transport process .

How do mutations in the LolD ATP-binding site affect lipoprotein transport function?

Mutations in the LolD ATP-binding site can significantly impact lipoprotein transport function in different ways:

The E171Q mutation has been particularly valuable in research, as it creates a catalytically dead mutant that can still bind ATP but cannot hydrolyze it. Experimental evidence shows that LolD(E171Q) allows the entry of lipoprotein substrates like RcsF into the LolCDE complex but prevents their transfer to LolA, indicating that ATP hydrolysis is specifically required for this transfer step rather than for initial substrate binding .

What structural changes occur in LolD during the ATP-binding and hydrolysis cycle?

Cryo-EM structural analysis has revealed significant conformational changes in LolD during the ATP cycle:

• In the apo state, LolD adopts an open conformation

• Upon binding of AMPPNP (a non-hydrolyzable ATP analog), LolD transitions to a closed conformation

• This closure brings the Walker A and Walker B motifs into proximity with the nucleotide

• The structural changes in LolD are transmitted to LolC and LolE, altering the V-shaped cavity

These conformational changes have been characterized at resolutions of 3.5 to 4.2 Å, providing detailed insights into the molecular mechanisms underlying LolD function . The structural transitions observed in different functional states (apo, lipoprotein-bound, and AMPPNP-bound) reveal how ATP binding and hydrolysis drive the lipoprotein transport cycle in E. coli.

What techniques are most effective for studying LolD-substrate interactions?

Several complementary techniques have proven effective for studying LolD-substrate interactions:

• Structure-based disulfide crosslinking: Introducing cysteine mutations at specific residues allows for verification of protein-protein interactions through disulfide bond formation.

• Photo-crosslinking: Incorporating photo-activatable amino acid analogs (like pBPA) at specific positions enables the capture of transient interactions upon UV exposure. This approach has been successfully used to detect interactions between LolCDE and lipoprotein substrates like RcsF .

• Functional complementation assays: These assays can verify the biological relevance of observed interactions by testing whether mutant proteins can rescue function in deficient strains.

• In vitro lipoprotein transfer assays: These assays directly measure the transfer of lipoproteins from LolCDE to LolA, allowing for assessment of ATP dependency and the effects of various mutations .

When designing experiments to study LolD-substrate interactions, it's important to consider both structural proximity (based on available cryo-EM structures) and functional relevance.

How can researchers troubleshoot problems with recombinant LolD expression and purification?

Common issues with LolD expression and purification can be addressed through the following strategies:

• Low expression levels:

  • Optimize codon usage for E. coli

  • Test different expression strains (BL21(DE3), Rosetta, etc.)

  • Adjust induction conditions (temperature, IPTG concentration)

  • Consider co-expression with chaperones

• Poor solubility:

  • Express LolD as part of the complete LolCDE complex

  • Lower induction temperature (16-20°C)

  • Use solubility-enhancing fusion tags (MBP, SUMO)

  • Optimize lysis and purification buffers

• Limited functionality:

  • Ensure proper folding by using strains with enhanced capacity for disulfide bond formation

  • Validate ATPase activity using colorimetric assays

  • Confirm protein integrity through thermal shift assays

  • Verify complex formation with LolC and LolE through size exclusion chromatography

For membrane proteins like the LolCDE complex, nanodisc reconstitution has proven effective for functional studies, allowing the complex to maintain its native conformation in a lipid bilayer environment .

What controls should be included in ATP hydrolysis assays involving LolD?

When designing ATP hydrolysis assays for LolD, the following controls should be included:

• Negative controls:

  • Heat-inactivated LolD to establish baseline readings

  • Catalytically inactive LolD(E171Q) mutant to distinguish between ATP binding and hydrolysis

  • Buffer-only samples to account for spontaneous ATP hydrolysis

• Positive controls:

  • Known ATPase with well-characterized activity

  • Wild-type LolD under optimal conditions

• Specificity controls:

  • Addition of ATPase inhibitors (vanadate, EDTA)

  • Non-hydrolyzable ATP analogs (AMPPNP)

  • Other nucleotides (GTP, CTP) to confirm ATP specificity

• Functional validation:

  • Parallel lipoprotein transfer assays to correlate ATP hydrolysis with transport function

  • Photo-crosslinking experiments to verify substrate interactions under various nucleotide conditions

Data from these controls should be presented in combination with experimental results to demonstrate the specificity and functionality of the observed ATP hydrolysis activity.

What are the latest advances in understanding LolD structure-function relationships?

Recent cryo-EM studies have provided unprecedented insights into the structure-function relationships of LolD within the LolCDE complex. These studies have captured the complex in three functional states (apo, lipoprotein-bound, and AMPPNP-bound) at resolutions of 3.5 to 4.2 Å . Key advances include:

• Elucidation of the V-shaped cavity formed by LolC and LolE that accommodates lipoprotein substrates

• Identification of two potential gates (Interface I and Interface II) for lipoprotein entry

• Discovery that lipoprotein entry is ATP-independent, while transport to LolA requires ATP hydrolysis

• Characterization of conformational changes induced by ATP binding and hydrolysis

These structural insights provide a molecular framework for understanding how LolD functions within the LolCDE complex to drive lipoprotein transport, opening new avenues for therapeutic targeting of this essential bacterial pathway.

How can peer researcher approaches enhance studies of LolD and other bacterial transport systems?

Incorporating peer researcher approaches can significantly enhance studies of complex bacterial transport systems like LolCDE:

• Collaborative expertise: Engaging researchers with complementary expertise (structural biology, biochemistry, microbiology) can provide more comprehensive insights into complex transport mechanisms.

• Method diversification: Combining multiple experimental approaches (structural studies, functional assays, computational modeling) strengthens the validity of findings and addresses limitations of individual methods.

• Co-research models: Following models used in other fields, co-research approaches can enhance the quality of research by bringing diverse perspectives . For LolD studies, this might involve collaboration between structural biologists, membrane protein specialists, and computational biologists.

Key considerations for effective peer researcher engagement include:

• Enhanced communication training to ensure effective collaboration

• Optimizing the number of peer researchers to balance workload and perspectives

• Identifying complementary skills that enable researchers to connect effectively

What are the potential applications of LolD research in antimicrobial development?

Research on LolD and the LolCDE complex offers promising avenues for antimicrobial development:

• Novel antibiotic targets: As an essential component of the lipoprotein transport system, LolD represents a potential target for new antibiotics. Compounds that inhibit LolD's ATPase activity could disrupt proper lipoprotein localization, compromising bacterial envelope integrity.

• Structure-based drug design: The high-resolution structures of LolCDE in different functional states provide templates for rational design of inhibitors targeting:

  • The ATP-binding site of LolD

  • Interfaces between LolD and other components of the complex

  • Conformational changes required for lipoprotein transport

• Screening approaches: Functional assays measuring ATP hydrolysis or lipoprotein transfer can be adapted for high-throughput screening of compound libraries to identify potential inhibitors.

• Species selectivity: Comparative analysis of LolD across different bacterial species may enable the development of narrow-spectrum antibiotics targeting specific pathogens while sparing beneficial microbiota.

Given the growing crisis of antimicrobial resistance, novel targets like LolD that are essential for bacterial viability but absent in mammalian cells represent valuable opportunities for antibiotic development.